
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1005 | 1005 | 1009 | 1117 | 1549 | 1855 |
Fund Return | 0.51% | 0.51% | 0.9% | 3.75% | 9.15% | 6.38% |
Place in category | 148 | 148 | 248 | 132 | 152 | 32 |
% in Category | 38 | 38 | 73 | 43 | 54 | 13 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Liontrust Special Situations Fund R | 26.46M | 1.87 | -1.97 | 6.72 | ||
Liontrust Special Situations Fund A | 2.45B | -0.17 | 2.28 | 6.77 | ||
Liontrust Special Situations Fund I | 2.45B | -4.92 | 0.39 | 6.44 | ||
Liontrust European Growth Fund A In | 1.83B | 8.50 | 11.23 | 11.98 | ||
Liontrust European Growth Fund I In | 1.83B | 4.37 | 8.39 | 11.50 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Artemis UK Select Fund I Acc | 4.01B | 0.90 | 12.67 | 9.00 | ||
Artemis UK Select Fund G Inc GBP | 3.56B | 5.79 | 13.25 | - | ||
Artemis UK Select Fund R Acc | 3.56B | 5.69 | 12.10 | 9.10 | ||
Artemis UK Select Fund I Inc GBP | 3.56B | 25.31 | 10.43 | 9.44 | ||
Fidelity Special Situations Fund W | 3.22B | 1.22 | 8.90 | 6.97 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
AstraZeneca | GB0009895292 | 9.47 | 9,975.0 | -0.43% | |
Shell | GB00BP6MXD84 | 8.50 | 26.80 | -1.45% | |
Unilever | GB00B10RZP78 | 5.76 | 53.32 | +0.60% | |
BP | GB0007980591 | 5.35 | 335.35 | -1.90% | |
GSK plc | GB00BN7SWP63 | 4.39 | 1,274.50 | -0.04% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Strong Sell | Sell |
Technical Indicators | Strong Sell | Strong Sell | Strong Sell |
Summary | Strong Sell | Strong Sell | Strong Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review